Showing results (1-10 of 164) with videos related to

Sort By:
Pageof 17
Journal of Molecular Histology|June 8, 2006
Role of SUMO/Ubc9 in DNA damage repair and tumorigenesisStergios J Moschos, Yin-Yuan Mo
Expert Opinion on Therapeutic Targets|November 23, 2005
Targeting Ubc9 for cancer therapyYin-Yuan Mo, Stergios J Moschos
American Journal of Clinical Dermatology|May 9, 2022
Melanoma Brain Metastases: An Update on the Use of Immune Checkpoint Inhibitors and Molecularly Targeted AgentsStergios J Moschos
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 19, 2022
War against NRAS-Mutant Melanoma Using Targeted Therapies Remains ChallengingStergios J Moschos
Surgical Oncology Clinics of North America|March 15, 2015
Targeted therapies in melanomaStergios J Moschos, Ramya Pinnamaneni
Expert Opinion on Biological Therapy|April 17, 2009
The use of endostatin in the treatment of solid tumorsMichalis V Karamouzis, Stergios J Moschos
Oncology|November 6, 2002
The role of the IGF system in cancer: from basic to clinical studies and clinical applicationsStergios J Moschos, Christos S Mantzoros
Genes & Cancer|July 23, 2011
Functional analysis and molecular targeting of aurora kinases a and B in advanced melanomaXiaolei Wang, Stergios J Moschos, Dorothea Becker
Oncology (Williston Park, N.Y.)|October 12, 2007
Integrins and cancerStergios J Moschos, Laura M Drogowski, Shelley L Reppert, et al.
Nature Clinical Practice. Oncology|December 19, 2008
Does pegylated interferon alpha-2b confer additional benefit in the adjuvant treatment of high-risk melanoma?John M Kirkwood, Hussein A Tawbi, Ahmad A Tarhini, et al.
Pageof 17